SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Masashi Utsumi, Akinobu Takaki, Yuzo Umeda, Kazuko Koike, Stephanie C. Napier, Nobukazu Watanabe, Hiroshi Sadamori, Susumu Shinoura, Ryuichi Yoshida, Daisuke Nobuoka, Tetsuya Yasunaka, Eiichi Nakayama, Kazuhide Yamamoto, Toshiyoshi Fujiwara, Takahito Yagi, Frequency of regulatory T-cell and hepatitis C viral antigen-specific immune response in recurrent hepatitis C after liver transplantation, Transplant Immunology, 2014, 31, 1, 33

    CrossRef

  2. You have free access to this content2
    Oyedele A. Adeyi, Common problems in liver allograft biopsy interpretation: Resolving clinical dilemmas, Clinical Liver Disease, 2013, 2, 4
  3. 3
    Pinelopi Manousou, Andrew K. Burroughs, Emmanuel T. Sochatzis, Grazia Isgro, Andrew Hall, Anna Green, Vincenza Calvaruso, Guang Li Ma, Jeremy Gale, Gary Burgess, James O’Beirne, David Patch, Douglas Thorburn, Gioacchino Leandro, Amar Paul Dhillon, Digital image analysis of collagen assessment of progression of fibrosis in recurrent HCV after liver transplantation, Journal of Hepatology, 2013, 58, 5, 962

    CrossRef

  4. 4
    Stefan G. Hübscher, Andrew D. Clouston, MacSween's Pathology of the Liver, 2012,

    CrossRef

  5. 5
    Corinne Buchanan, Tram T. Tran, Current Status of Liver Transplantation for Hepatitis B Virus, Clinics in Liver Disease, 2011, 15, 4, 753

    CrossRef

  6. 6
    Rosalba Minisini, Paola Giarda, Glenda Grossi, Davide Bitetto, Pierluigi Toniutto, Edmondo Falleti, Claudio Avellini, Giuseppa Occhino, Carlo Fabris, Mario Pirisi, Early activation of interferon-stimulated genes in human liver allografts: relationship with acute rejection and histological outcome, Journal of Gastroenterology, 2011, 46, 11, 1307

    CrossRef

  7. 7
    T. Casanovas, A. Argudo, M.C. Peña-Cala, Effectiveness and Safety of Everolimus in the Treatment of Autoimmune Hepatitis Related to Anti-Hepatitis C Virus Therapy After Liver Transplant: Three Case Reports, Transplantation Proceedings, 2011, 43, 6, 2233

    CrossRef

  8. 8
    Mathieu Daudé, Lionel Rostaing, Karine Sauné, Laurence Lavayssière, Grégoire Basse, Laure Esposito, Joelle Guitard, Jacques Izopet, Laurent Alric, Nassim Kamar, Tenofovir Therapy in Hepatitis B Virus-Positive Solid-Organ Transplant Recipients, Transplantation, 2011, 91, 8, 916

    CrossRef

  9. 9
    A. Perrakis, S. Yedibela, S. Schuhmann, R. Croner, V. Schellerer, R. Demir, W. Hohenberger, V. Müller, The Effect and Safety of the Treatment of Recurrent Hepatitis C Infection After Orthotopic Liver Transplantation With Pegylated Interferon α2b and Ribavirin, Transplantation Proceedings, 2011, 43, 10, 3824

    CrossRef

  10. 10
    John O'Grady, The immunoreactive patient: Rejection and autoimmune disease, Liver Transplantation, 2011, 17, S3
  11. 11
    Stefan G. Hübscher, What is the long-term outcome of the liver allograft?, Journal of Hepatology, 2011, 55, 3, 702

    CrossRef

  12. 12
    Romil Saxena, Swan N. Thung, Practical Hepatic Pathology: A Diagnostic Approach, 2011,

    CrossRef

  13. 13
    Elena Vezali, Alessio Aghemo, Massimo Colombo, A review of the treatment of chronic hepatitis C virus infection in cirrhosis, Clinical Therapeutics, 2010, 32, 13, 2117

    CrossRef

  14. 14
    Sven C. Schmidt, Marcus Bahra, Sandra Bayraktar, Thomas Berg, Maximilian Schmeding, Johann Pratschke, Peter Neuhaus, Ulf Neumann, Antiviral Treatment of Patients with Recurrent Hepatitis C After Liver Transplantation with Pegylated Interferon, Digestive Diseases and Sciences, 2010, 55, 7, 2063

    CrossRef

  15. 15
    W.-C. Lee, T.-J. Wu, H.-S. Chou, C.-F. Lee, K.-M. Chan, S.-S. Cheng, Flexible and individualized treatment to achieve sustained viral response for recurrent hepatitis C in liver transplant recipients, Journal of Viral Hepatitis, 2010, 17, 11
  16. 16
    A.E. Shafii, J.W. Su, N.G. Smedira, J.L. Navia, D.O. Taylor, R.C. Starling, G. Gonzalez-Stawinski, The Effect of Recipient Hepatitis C Virus Infection on Outcomes Following Heart Transplantation, Transplantation Proceedings, 2010, 42, 5, 1784

    CrossRef

  17. 17
    Roberto J. Firpi, Consuelo Soldevila-Pico, Giuseppe G. Morelli, Roniel Cabrera, Cynthia Levy, Virginia C. Clark, Amitabh Suman, Anthony Michaels, Chaoru Chen, David R. Nelson, The Use of Cyclosporine for Recurrent Hepatitis C After Liver Transplant: A Randomized Pilot Study, Digestive Diseases and Sciences, 2010, 55, 1, 196

    CrossRef

  18. 18
    Tim C. M. A. Schreuder, Stefan G. Hübscher, James Neuberger, Autoimmune liver diseases and recurrence after orthotopic liver transplantation: what have we learned so far?, Transplant International, 2009, 22, 2
  19. 19
    G. Germani, M. Pleguezuelo, F. Villamil, S. Vaghjiani, E. Tsochatzis, L. Andreana, A. K. Burroughs, Azathioprine in Liver Transplantation: A Reevaluation of Its Use and a Comparison with Mycophenolate Mofetil, American Journal of Transplantation, 2009, 9, 8
  20. 20
    M. Merli, F. Gentili, M. Giusto, A.F. Attili, S.G. Corradini, G. Mennini, M. Rossi, A. Corsi, P. Bianco, Immune-mediated liver dysfunction after antiviral treatment in liver transplanted patients with hepatitis c: Allo or autoimmune de novo hepatitis?, Digestive and Liver Disease, 2009, 41, 5, 345

    CrossRef

  21. 21
    Inmaculada Fernández, Esperanza Ulloa, Francisco Colina, Manuel Abradelo, Carlos Jiménez, Alberto Gimeno, Juan Carlos Meneu, Carlos Lumbreras, José Antonio Solís-Herruzo, Enrique Moreno, Incidence, risk factors, and outcome of chronic rejection during antiviral therapy for posttransplant recurrent hepatitis C, Liver Transplantation, 2009, 15, 8
  22. 22
    A. Carpentier, F. Conti, F. Stenard, L. Aoudjehane, C. Miroux, P. Podevin, O. Morales, S. Chouzenoux, O. Scatton, H. Groux, C. Auriault, Y. Calmus, V. Pancre, N. Delhem, Increased Expression of Regulatory Tr1 Cells in Recurrent Hepatitis C after Liver Transplantation, American Journal of Transplantation, 2009, 9, 9
  23. 23
    Thomas Walter, Jean-Yves Scoazec, Olivier Guillaud, Valérie Hervieu, Philippe Chevallier, Olivier Boillot, Jérôme Dumortier, Long-term antiviral therapy for recurrent hepatitis C after liver transplantation in nonresponders: Biochemical, virological, and histological impact, Liver Transplantation, 2009, 15, 1
  24. 24
    Pinelopi Manousou, Dimitrios Samonakis, Evangelos Cholongitas, David Patch, James O'Beirne, Amar P. Dhillon, Keith Rolles, Aiden McCormick, Peter Hayes, Andrew K. Burroughs, Outcome of recurrent hepatitis C virus after liver transplantation in a randomized trial of tacrolimus monotherapy versus triple therapy, Liver Transplantation, 2009, 15, 12
  25. 25
    Natasha Walzer, Steven L Flamm, Pegylated IFN-α and ribavirin: emerging data in the treatment of special populations, Expert Review of Clinical Pharmacology, 2009, 2, 1, 67

    CrossRef

  26. 26
    A.J. DEMETRIS, JAMES M. CRAWFORD, MARTA IDA MINERVINI, MIKE NALESNIK, ERIN OCHOA, PARMJEET RANDHAWA, EIZABURO SASATOMI, TONG WU, Surgical Pathology of the GI Tract, Liver, Biliary Tract, and Pancreas, 2009,

    CrossRef

  27. 27
    Sandeep Mukherjee, Michael F. Sorrell, Controversies in Liver Transplantation for Hepatitis C, Gastroenterology, 2008, 134, 6, 1777

    CrossRef

  28. 28
    Nassim Kamar, Olivier Milioto, Laurent Alric, Labib El Kahwaji, Olivier Cointault, Laurence Lavayssière, Karine Sauné, Jacques Izopet, Lionel Rostaing, Entecavir Therapy for Adefovir-Resistant Hepatitis B Virus Infection in Kidney and Liver Allograft Recipients, Transplantation, 2008, 86, 4, 611

    CrossRef

  29. 29
    Bruno Roche, Mylene Sebagh, Maria Laura Canfora, Teresa Antonini, Anne-Marie Roque-Afonso, Valerie Delvart, Faouzi Saliba, Jean-Charles Duclos-Vallee, Denis Castaing, Didier Samuel, Hepatitis C virus therapy in liver transplant recipients: Response predictors, effect on fibrosis progression, and importance of the initial stage of fibrosis, Liver Transplantation, 2008, 14, 12
  30. 30
    Emily B Ahmed, Maria-Luisa Alegre, Anita S Chong, Role of bacterial infections in allograft rejection, Expert Review of Clinical Immunology, 2008, 4, 2, 281

    CrossRef

  31. 31
    Elena Oton, Rafael Barcena, Severe Hepatitis C Recurrence: Is It a Negative Predictive Factor for Sustained Response to Treatment?, Gastroenterology, 2008, 134, 1, 367

    CrossRef

  32. 32
    Arno Kornberg, Bernadett Küpper, Andrea Tannapfel, Katharina Thrum, Erik Bärthel, Ola Habrecht, Utz Settmacher, Sustained Clearance of Serum Hepatitis C Virus-RNA Independently Predicts Long-Term Survival in Liver Transplant Patients With Recurrent Hepatitis C, Transplantation, 2008, 86, 3, 469

    CrossRef

  33. 33
    Maria-Luisa Alegre, Jaklien Leemans, Alain Le Moine, Sandrine Florquin, Virginie De Wilde, Anita Chong, Michel Goldman, The Multiple Facets of Toll-Like Receptors in Transplantation Biology, Transplantation, 2008, 86, 1, 1

    CrossRef

  34. 34
    Olivier Boillot, Jérôme Dumortier, Immunosuppression in HCV-positive liver transplant recipients: Pandora's box?, Liver Transplantation, 2007, 13, 11
  35. 35
    Ed Gane, Liver Transplantation for Chronic Hepatitis B and C,
  36. 36
    Maria Pleguezuelo, Giacomo Germani, Andrew K Burroughs, Liver Transplantation: Prevention and Treatment of Rejection,
  37. 37
    Ed Gane, Prevention and Treatment of Recurrent HBV and HCV Infection,
  38. 38
    Ed Gane, Treatment of Recurrent Hepatitis C Following Liver Transplantation,